130 related articles for article (PubMed ID: 35930824)
1. SOX2 and PRAME in the "reprogramming" of seminoma cells.
Orsatti A; Sirolli M; Ambrosi F; Franceschini T; Giunchi F; Franchini E; Grillini M; Massari F; Mollica V; Bianchi FM; Colecchia M; Fiorentino M; Ricci C
Pathol Res Pract; 2022 Sep; 237():154044. PubMed ID: 35930824
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia In Situ, and Germ Cell Tumors of the Testis.
Ricci C; Franceschini T; Giunchi F; Grillini M; Ambrosi F; Massari F; Mollica V; Colecchia M; Fiorentino M
Am J Clin Pathol; 2022 May; 157(5):644-648. PubMed ID: 34864837
[TBL] [Abstract][Full Text] [Related]
3. TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis.
Melotti S; Ambrosi F; Franceschini T; Giunchi F; Filippo GD; Franchini E; Massari F; Mollica V; Tateo V; Bianchi FM; Colecchia M; Acosta AM; Lobo J; Fiorentino M; Ricci C
Pathol Res Pract; 2023 Jul; 247():154540. PubMed ID: 37209574
[TBL] [Abstract][Full Text] [Related]
4. SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate.
Nettersheim D; Heimsoeth A; Jostes S; Schneider S; Fellermeyer M; Hofmann A; Schorle H
Oncotarget; 2016 Jul; 7(30):47095-47110. PubMed ID: 27283990
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors - A comparative study with SOX17.
Zhou Y; Rothrock A; Murugan P; Li F; Bu L
Exp Mol Pathol; 2022 Jun; 126():104761. PubMed ID: 35390309
[TBL] [Abstract][Full Text] [Related]
6. Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate.
Jostes SV; Fellermeyer M; Arévalo L; Merges GE; Kristiansen G; Nettersheim D; Schorle H
Int J Cancer; 2020 Mar; 146(6):1592-1605. PubMed ID: 31583686
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of SOX2 and SOX17 in testicular germ cell tumors.
Nonaka D
Am J Clin Pathol; 2009 May; 131(5):731-6. PubMed ID: 19369635
[TBL] [Abstract][Full Text] [Related]
8. The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas.
Nettersheim D; Arndt I; Sharma R; Riesenberg S; Jostes S; Schneider S; Hölzel M; Kristiansen G; Schorle H
Br J Cancer; 2016 Aug; 115(4):454-64. PubMed ID: 27441500
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of SOX2 inhibition for embryonal carcinoma.
Ushida H; Chano T; Minami K; Kita H; Kawakami T; Okabe H; Okada Y; Okamoto K
J Urol; 2012 May; 187(5):1876-81. PubMed ID: 22425046
[TBL] [Abstract][Full Text] [Related]
10. The plasticity of germ cell cancers and its dependence on the cellular microenvironment.
Nettersheim D; Schorle H
J Cell Mol Med; 2017 Aug; 21(8):1463-1467. PubMed ID: 28244655
[TBL] [Abstract][Full Text] [Related]
11. MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors.
Bode PK; Barghorn A; Fritzsche FR; Riener MO; Kristiansen G; Knuth A; Moch H
Mod Pathol; 2011 Jun; 24(6):829-35. PubMed ID: 21780320
[TBL] [Abstract][Full Text] [Related]
12. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors.
Biermann K; Heukamp LC; Steger K; Zhou H; Franke FE; Sonnack V; Brehm R; Berg J; Bastian PJ; Muller SC; Wang-Eckert L; Buettner R
Cancer Genomics Proteomics; 2007; 4(5):359-67. PubMed ID: 17993720
[TBL] [Abstract][Full Text] [Related]
14. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.
Gillis AJ; Stoop H; Biermann K; van Gurp RJ; Swartzman E; Cribbes S; Ferlinz A; Shannon M; Oosterhuis JW; Looijenga LH
Int J Androl; 2011 Aug; 34(4 Pt 2):e160-74. PubMed ID: 21631526
[TBL] [Abstract][Full Text] [Related]
15. Analysis of SOX2 expression in developing human testis and germ cell neoplasia.
Sonne SB; Perrett RM; Nielsen JE; Baxter MA; Kristensen DM; Leffers H; Hanley NA; Rajpert-De-Meyts E
Int J Dev Biol; 2010; 54(4):755-60. PubMed ID: 19876845
[TBL] [Abstract][Full Text] [Related]
16. Role of SOX2 in the etiology of embryonal carcinoma, based on analysis of the NCCIT and NT2 cell lines.
Eini R; Stoop H; Gillis AJ; Biermann K; Dorssers LC; Looijenga LH
PLoS One; 2014; 9(1):e83585. PubMed ID: 24404135
[TBL] [Abstract][Full Text] [Related]
17. On the origin of germ cell neoplasia in situ: Dedifferentiation of human adult Sertoli cells in cross talk with seminoma cells in vitro.
Fink C; Baal N; Wilhelm J; Sarode P; Weigel R; Schumacher V; Nettersheim D; Schorle H; Schröck C; Bergmann M; Kliesch S; Kressin M; Savai R
Neoplasia; 2021 Jul; 23(7):731-742. PubMed ID: 34153645
[TBL] [Abstract][Full Text] [Related]
18. H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma.
Ricci C; Ambrosi F; Franceschini T; Giunchi F; Maracci ME; Sirolli M; Orsatti A; Chiarucci F; Franchini E; Borsato M; Massari F; Mollica V; Bianchi FM; Colecchia M; Acosta AM; Fiorentino M
Pathol Res Pract; 2023 Feb; 242():154337. PubMed ID: 36706585
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of immunohistochemistry and FISH for chromosome 12p in type Ⅱ testicular germ cell tumors].
Shen Q; Rao Q; Yu B; Xia QY; Bao W; Lu ZF; Shi QL; Zhou XJ
Zhonghua Nan Ke Xue; 2016 Aug; 22(8):692-697. PubMed ID: 29019224
[TBL] [Abstract][Full Text] [Related]
20. Seminoma component of mixed testicular germ cell tumor shows a higher incidence of loss of heterozygosity than pure-type seminoma.
Miyai K; Ito K; Nakanishi K; Tsuda H
Hum Pathol; 2019 Feb; 84():71-80. PubMed ID: 30266250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
